← Back to Vital Edge Science
← Back to Vital Edge Science Compound Comparison Tool

How are these compounds
scientifically different?

Compare mechanisms, targets, research profiles and pharmacokinetics for up to 4 compounds side by side. This maps what is scientifically known — it does not tell you which compound to choose.

This is a scientific comparison, not a recommendation. It does not answer "which should I take?" — for potential combination-specific considerations, see the Interaction Checker; for regulatory/clinical-development history, see the Research Status Explorer.

MOTS-c × 5-Amino-1MQ × 2 of 4 selected View comparison

MOTS-c

Mitochondrial-derived peptide

Remove
VS

5-Amino-1MQ

NNMT inhibitor

Remove

Target & Mechanism Comparison

Primary molecular targets for each selected compound, drawn directly from each compound's structured scientific record. Not every compound has a single conventional receptor target — where that's the case, its differentiating mechanism is noted below instead.

← Scroll to see all compounds →

Target MOTS-c5-Amino-1MQ
✓ —
— ✓

What These Compounds Share

Shared research line

All selected compounds are catalogued under Metabolic.

Shared pathway tags
Metabolic

Key Differences

MOTS-c AMPK-associated is a direct target of MOTS-c that none of the other selected compounds share. Mitochondrial-encoded signalling peptide rather than a conventional extracellular hormone/receptor agonist.
5-Amino-1MQ NNMT is a direct target of 5-Amino-1MQ that none of the other selected compounds share. The only small-molecule enzyme inhibitor in the current catalogue.

Compound Detail

MOTS-c
What is it?
A tiny peptide made by your own mitochondria -- the energy factories inside your cells.
What are people researching/using it for?
Studied for its role in metabolism, energy use and exercise-related biology.
Other uses being trialed
Insulin sensitivity researchAge-related metabolic decline
Worth knowing
CB4211 is a modified MOTS-c analogue studied in separate human trials -- those findings are not transferred to native MOTS-c here.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
Mitochondrial-derived peptide encoded by the 12S rRNA region, implicated in metabolic stress-response signalling.
16-amino-acid mitochondrial-encoded peptide · 16 amino acids · Endogenous (mitochondrial-encoded)
Primary Targets & Biological System
Mitochondrial / metabolic signalling

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
Unlike the receptor-agonist peptides elsewhere in this catalogue, MOTS-c is not known to act through a single cell-surface receptor. It is encoded within the mitochondrial genome (the 12S rRNA region) and, in preclinical research, has been shown to translocate to the nucleus under metabolic stress and interact with AMPK-associated signalling -- a pathway broadly involved in how cells sense and respond to low energy availability. This mitochondrial-to-nuclear signalling mechanism is mechanistically distinct from a conventional hormone-receptor interaction, and the foundational work establishing it (Lee et al., 2015) was conducted in mice, not humans.
Research Areas
Mitochondrial biologyMetabolic homeostasisGlucose metabolismInsulin sensitivityExercise physiologyCellular stressAge-associated metabolic biology
Research Profile
Human administration: None identified Human observational: Available Preclinical: Extensive
Pharmacokinetics
Not adequately established
Research Routes
Subcutaneous (preclinical research) (descriptive only — not administration or dosing guidance)
Key Differentiator
Mitochondrial-encoded signalling peptide rather than a conventional extracellular hormone/receptor agonist.
Considerations
Research Limitations
CB4211 is a modified MOTS-c analogue studied in separate human trials -- those findings are not transferred to native MOTS-c here.
Availability & Sources
Current Vital Edge Testing
Available As (Vital Edge Science)
MOTS-c · A$159.95 A$179.95
Browse products →
View Research Sources (1) →
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Cell Metabolism, 2015 · Preclinical (animal) Mouse · PMID 25738459 · DOI 10.1016/j.cmet.2015.02.009

Foundational mouse mechanistic work -- not converted into a human therapeutic claim on this record.

Supports: mechanism_summary, research_areas

5-Amino-1MQ
What is it?
A small lab-made molecule (not a peptide) that blocks a specific metabolism-related enzyme.
What are people researching/using it for?
Studied in animal models for fat metabolism and body composition.
Other uses being trialed
General metabolic research -- still early-stage, no human studies yet
Worth knowing
No established human administration research identified -- current evidence is preclinical.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
An NNMT inhibitor investigated in relation to nicotinamide metabolism, methyl-donor metabolism and NAD-linked metabolic pathways.
Small molecule -- not a peptide · Synthetic small molecule
Primary Targets & Biological System
Nicotinamide / NAD-linked metabolism

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
A small molecule that inhibits NNMT, an enzyme that transfers a methyl group onto nicotinamide (a B3-vitamin-related compound) as part of its breakdown. Because this reaction consumes methyl donors and intersects with NAD+ metabolism, inhibiting NNMT has been investigated in mouse models for effects on adipose tissue metabolism and body weight. This mechanistic link between NNMT activity, methyl-donor availability and metabolic outcomes has substantial preclinical support but has not yet been evaluated in human trials.
Research Areas
NNMT biologyMetabolismAdipose biologyNAD-related metabolismSkeletal-muscle/metabolic research
Research Profile
Human administration: None identified Preclinical: Available
Pharmacokinetics
Not established
Research Routes
Not established in humans (descriptive only — not administration or dosing guidance)
Key Differentiator
The only small-molecule enzyme inhibitor in the current catalogue.
Considerations
Research Limitations
No established human administration research identified -- current evidence is preclinical.
Availability & Sources
Current Vital Edge Testing
No current batch testing on file yet.
Available As (Vital Edge Science)
5-Amino-1MQ · A$149.95 A$169.95
Browse products →
View Research Sources (1) →
Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction
Preclinical (animal) Mouse · PMID 39161060

Mouse work -- its PK/metabolic findings are not presented as human PK on this record.

Supports: mechanism_summary, human_administration_status

Common Research Comparisons

Frequently studied groupings — not recommendations.

Browse more compounds

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Choose a compound

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Simplified for general understanding — see this compound's "How does it work?" section for the full research-level description.